Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells.
about
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelChaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells.Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK.Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma.Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
P2860
Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sarcoplasmic reticulum Ca(2+) ...... ocyte-derived dendritic cells.
@en
type
label
Sarcoplasmic reticulum Ca(2+) ...... ocyte-derived dendritic cells.
@en
prefLabel
Sarcoplasmic reticulum Ca(2+) ...... ocyte-derived dendritic cells.
@en
P2093
P2860
P356
P1476
Sarcoplasmic reticulum Ca(2+) ...... nocyte-derived dendritic cells
@en
P2093
Cheol Yi Hong
Hyeoung-Joon Kim
Hyun-Ju Lee
Je-Jung Lee
Manh-Cuong Vo
My Dung Hoang
Nu-Ri Choi
P2860
P2888
P356
10.1038/EMM.2016.69
P577
2016-08-19T00:00:00Z